| scholarly article | Q13442814 |
| P50 | author | Carol M Mangione | Q92011752 |
| P2093 | author name string | Chi-Hong Tseng | |
| Norman Turk | |||
| O Kenrik Duru | |||
| Lindsay Kimbro | |||
| Susan Ettner | |||
| Sarah Edgington | |||
| P2860 | cites work | Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents | Q28174787 |
| Heart disease and stroke statistics--2012 update: a report from the American Heart Association | Q29547909 | ||
| Cognition and take-up of subsidized drug benefits by Medicare beneficiaries | Q33355816 | ||
| Using matched survey and administrative data to estimate eligibility for the Medicare Part D low-income subsidy program. | Q33608904 | ||
| 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi | Q34231154 | ||
| Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. | Q34732970 | ||
| Clopidogrel use and early outcomes among older patients receiving a drug-eluting coronary artery stent | Q35680854 | ||
| Exploring patients' reasons for discontinuance of heart medications | Q35956390 | ||
| Validity of a prescription claims database to estimate medication adherence in older persons | Q36461386 | ||
| Predictors of low clopidogrel adherence following percutaneous coronary intervention | Q36651538 | ||
| Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behaviour vs. drug effects and 10-year follow-up of outcome | Q36792770 | ||
| The demand for statin: the effect of copay on utilization and compliance. | Q36856495 | ||
| Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population | Q37180258 | ||
| Responses to Medicare drug costs among near-poor versus subsidized beneficiaries | Q37228401 | ||
| Implementing critical pathways and a multidisciplinary team approach to cardiovascular disease management | Q37250188 | ||
| Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. | Q37365655 | ||
| How Medicare Part D benefit phases affect adherence with evidence-based medications following acute myocardial infarction | Q37421733 | ||
| Quality of care, health care costs, and utilization among Medicare Part D enrollees with and without low-income subsidy. | Q37982141 | ||
| Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment | Q42616762 | ||
| Adverse events associated with prescription drug cost-sharing among poor and elderly persons | Q42644645 | ||
| Evidence that value-based insurance can be effective | Q42646522 | ||
| Pharmacy cost sharing, antiplatelet therapy utilization, and health outcomes for patients with acute coronary syndrome. | Q42656773 | ||
| The relationship between the low-income subsidy and cost-related nonadherence to drug therapies in Medicare Part D. | Q43722424 | ||
| Lessons learned: who didn't enroll in Medicare drug coverage in 2006, and why? | Q46204210 | ||
| Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome | Q46770154 | ||
| Medicare Part D: state and local efforts to assist vulnerable beneficiaries | Q47680908 | ||
| Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. | Q51182242 | ||
| Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study. | Q51719123 | ||
| Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. | Q52643133 | ||
| Full Coverage for Preventive Medications after Myocardial Infarction | Q56872760 | ||
| Survival after coronary revascularization in the elderly | Q74137671 | ||
| Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study | Q79421834 | ||
| Impact of statin copayments on adherence and medical care utilization and expenditures | Q79437194 | ||
| Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database | Q82141175 | ||
| Long-term paclitaxel-eluting stent outcomes in elderly patients | Q82328099 | ||
| Factors associated with clopidogrel use, adherence, and persistence in patients with acute coronary syndromes undergoing percutaneous coronary intervention | Q83220921 | ||
| Eligibility and take-up of the Medicare Part D low-income subsidy | Q85644322 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | clopidogrel | Q410237 |
| P304 | page(s) | 1230-1238 | |
| P577 | publication date | 2014-10-14 | |
| P1433 | published in | Pharmacotherapy | Q7180800 |
| P1476 | title | Association of Medicare Part D low-income cost subsidy program enrollment with increased fill adherence to clopidogrel after coronary stent placement | |
| P478 | volume | 34 |
| Q42694880 | Adherence to tyrosine kinase inhibitors among Medicare Part D beneficiaries with chronic myeloid leukemia |
| Q92354089 | Decomposing the effect of drug benefit program on antihypertensive medication adherence among the elderly in urban China |
| Q38915260 | Medicare Part D's Effects on Drug Utilization and Out-of-Pocket Costs: A Systematic Review. |
Search more.